NovoCure Ltd (NASDAQ: NVCR) stock closed at $14.85 on 1/8/24 after a major increase of 11.6%. Moreover, above average trading volume at 134% of normal accompanied the advance. The stock has been extremely weak relative to the market over the last nine months and has declined -5.9% during the last week.
Current PriceTarget Research Rating
NVCR’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
NovoCure has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. NovoCure has a very low Appreciation Score of 10 and a very low Power Rating of 8, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment